Protara Therapeutics, Inc. (TARA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Protara Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.97x | -2.44x | -0.53x | -0.46x | -1.60x | -5.15x |
| P/B Ratio | 1.16x | 0.65x | 0.31x | 0.30x | 0.47x | 0.88x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 14.58x | 15.71x | 11.17x | 15.01x | 21.66x | 58.13x |
| Quick Ratio | 14.58x | 15.71x | 11.17x | 14.81x | 21.66x | 58.13x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.03x | 0.08x | 0.06x | 0.04x | 0.01x |
YoY = year-over-year change. Source: FMP..